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Abstract
Background: The association between Helicobacter pylori infection and upper gastrointestinal disease is well
established. However, only a small fraction of H. pylori carriers develop disease, and there are great geographical
differences in disease penetrance. The explanation to this enigma lies in the interaction between the bacterium
and the host. H. pylori Outer Membrane Phospholipase A (OMPLA) has been suggested to play a role in the
virulence of this bacterium. The aim of this study was to profile the most significant cellular pathways and
biological processes affected in gastric epithelial cells during 24 h of H. pylori exposure, and to study the
inflammatory response to OMPLA
+ and OMPLA
- H. pylori variants.
Results: Interleukin-8 was the most significantly up-regulated gene and appears to play a paramount role in the
epithelial cell response to H. pylori infection and in the pathological processes leading to gastric disease. MAPK and
NF-kappaB cellular pathways were powerfully activated, but did not seem to explain the impressive IL-8 response.
There was marked up-regulation of TP53BP2, whose corresponding protein ASPP2 may interact with H. pylori CagA
and cause marked p53 suppression of apoptosis. Other regulators of apoptosis also showed abberant regulation.
We also identified up-regulation of several oncogenes and down-regulation of tumor suppressor genes as early as
during the first 24 h of infection. H. pylori OMPLA phase variation did not seem to influence the inflammatory
epithelial cell gene response in this experiment.
Conclusion: In whole genome analysis of the epithelial response to H. pylori exposure, IL-8 demonstrated the most
marked up-regulation, and was involved in many of the most important cellular response processes to the
infection. There was dysregulation of apoptosis, tumor suppressor genes and oncogenes as early as in the first 24
ho fH. pylori infection, which may represent early signs of gastric tumorigenesis. OMPLA
+/-did not affect the acute
inflammatory response to H. pylori.
Background
H. pylori is well established as the primary cause of pep-
tic ulcer disease and the initiator of the multistep cas-
cade leading to gastric adenocarcinoma. Although
gastric cancer is the fourth most common cancer world-
wide and second only to lung cancer in causing cancer
related deaths [1], there arer e m a r k a b l ed i f f e r e n c e si n
the distribution of this disease between western and
eastern countries. The decrease in gastric cancer paral-
lels H. pylori prevalence in the western world, but this
phenomenon does not completely explain the great geo-
graphical differences in gastric cancer distribution. The
reason why only 1-2% of H. pylori-infected individuals
develop gastric malignancies remains unexplained, and
includes both differences in bacterial strains, most
importantly cagA status, host genetics and environmen-
tal aspects.
H. pylori carcinogenesis involves indirect action of the
bacteria through chronic inflammation of the gastric
corpus mucosa, and also direct action of H. pylori on
epithelial cells. Persistent inflammation is associated
with enhanced production of several pro-inflammatory
cytokines, such as IL-1b,T N F - a, IL-6, IL-7 and IL-8 [2]
which increase apoptosis, hyperproliferation and
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causing DNA damage and mutations. In addition, direct
action of H. pylori on epithelial cells may also promote
carcinogenesis. cagA
+ H. pylori strains inject bacterial
products into epithelial cells through a sophisticated
type IV injection process, which activates intracellular
signaling pathways, in particular the mitogen-activated
protein kinase family (MAPK) pathway [3] and nuclear
factor kappa B (NF-B), and may facilitate epithelial-
mesenchymal transition [4], all of which may contribute
to neoplastic transformation. Furthermore, tumor devel-
opment is associated with proliferation and apoptosis
inhibition [5,6], whereas excessive apoptosis is thought
to promote gastric ulcer formation. The effect of H.
pylori on gastric epithelial apoptosis has showed con-
flicting evidence. Several in vitro studies have showed
that H. pylori stimulate apoptosis [7,8], whereas some in
vivo studies demonstrate inhibition of apoptosis [9,10].
CagA injection into gastric epithelial cells up-regulates
the anti-apoptotic MCL protein [11] and interferes with
apoptosis-stimulating protein 2 of p53 (ASPP2) [12].
ASPP2 inhibition causes enhanced degradation of p53,
in a way similar to DNA tumor viruses, thereby decreas-
ing apoptotic activity, which may explain the increased
risk of GC associated with cagA
+ H. pylori infection.
Tannæs et al. have previously reported that the H.
pylori pldA gene, coding for bacterial outer membrane
phospholipase A (OMPLA), displays phase variation
resulting in ‘ON’ (OMPLA
+)a n d‘OFF’ (OMPLA
-)
switching of OMPLA activity due to a spontaneous slip-
page in a homopolymer (C) tract of the gene [13]. The
OMPLA
+ variant was associated with increased bacterial
survival in an acidic environment, adherence, hemolysis
and release of urease and VacA compared to the
OMPLA
- variant [14]. OMPLA has also been implicated
in the virulence of other gastrointestinal pathogens [15],
and a link between OMPLA activity and gastric inflam-
mation has been suggested in a previous study [16].
Although the gastric epithelial cell response to H.
pylori exposure has been subjected to many experiments
since the discovery of the bacterium in 1984 [17], only a
few studies have utilized cDNA microarray technology
[18-29]. Almost all of these experiments have been per-
formed on Asian H. pylori strains, and no authors have
compared the epithelial cell response to OMPLA
+
against OMPLA
- bacteria. The aim of the current study
was to investigate the temporal gene expression
response of gastric epithelial cells exposed to a clinically
obtained H. pylori strain, and to examine the contribu-
tion of OMPLA on the inflammatory response. Empha-
sis has been put on the most important biological
responses using Gene Ontology (GO) terms and asso-
ciated cellular signaling pathways.
Results
To study the cellular morphology following H. pylori
i n f e c t i o na t3a n d6h ,n o n - e x p o s e da n dH. pylori
exposed cells were stained and examined with immuno-
fluorescence microscopy (Figure 1). At both 3 and 6 h
there was no significant difference in the ability between
the OMPLA
+ and OMPLA
- H. pylori to adhere to AGS
cells, and there were no significant differences in the
morphological changes in the AGS cells in response to
exposure to the two variants. We were not able to iden-
tify any statistically significant differences in the gene
expression between the cells exposed to OMPLA
+ and
OMPLA
- variants at any time point over the 24 h of co-
culture (p < 0.05). We therefore concluded that analysis
of the results could be performed without further con-
sideration of differences in phase variation.
The cDNA profile of H. pylori exposed AGS cells were
compared against non-infected control cells at six sepa-
rate time points within 24 h. 7498 chip probes corre-
sponding to 6237 human genes showed differential
expression in the infected cells compared to control
cells at no less than 1 time point (p < 0. 05) (Additional
file 1: Table S1). The number of significantly differen-
tially expressed genes at each time point compared to
non-infected AGS-cells, and how they overlap at differ-
ent time points are illustrated in Table 1 and Figure 2.
There were no significantly expressed genes at 0.5 h, a
moderate increase in the number of genes from 1 to 6
h, and a 20-fold increase from 6 to 24 h. From one sam-
pling point to the next, most genes overlap, however a
considerable number of unique genes were also differen-
tially regulated at each time point (Figure 2). Approxi-
mately 47% of the total number of significantly
expressed genes were up-regulated, and 53% showed
down-regulation compared to control. Among the more
than 6000 significantly expressed genes, IL-8 was the
single most differentially expressed gene (Figure 3).
The list of all significant genes was analyzed for asso-
ciated Kyoto Encyclopedia of Genes and Genomes
(KEGG) signal pathways by Pathway Express at each
time point. Significantly impacted pathways and corre-
sponding Impact Factor (IF) are presented in Table 2.
E a r l yr e s p o n s es i g n a lp a t h w a y st h a tw e r es i g n i f i c a n t l y
affected included the epithelial cell signaling in H. pylori
infection pathway, cytokine-cytokine receptor interac-
tion, Toll-like receptor (TLR) signaling pathways as well
as many cancer-related pathways and immunological
pathways. At 1 h, IL-8 w a si n v o l v e di nm o s to ft h e
affected signal pathways. At 3 and 6 h, most of the high-
est ranked pathways had several genes in common, such
as NFKB1, NFKB2, NFKBIA, NFKBIE, BIRC2, BIRC3,
JUND, CCND1 and AKT3. The phosphatidylinositol sig-
naling system is assigned a high IF at 6 h due to the
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down-regulated by a log2FC of -0.58 and plays a key
role in this pathway. At 12 h, the most affected cellular
pathways were the leukocyte transendothelial migration,
cell adhesion molecules, DNA replication pathway, p53
signaling pathway as well as several cancer-related path-
ways. Relatively similar results are seen at 24 h, however
some of the cancer-related pathways are represented
Figure 1 Immunofluorescence images of AGS cells exposed to H. pylori. AGS cells were non-exposed, or exposed to OMPLA
+ and OMPLA
-
H. pylori at a MOI of 300:1 and co-cultured for 3 and 6 h. The bacteria were stained with rabbit anti-Helicobacter antibody. Images were
captured by fluorescent microscopy.
Table 1 Number of differentially regulated genes
Time 0.5 1 3 6 12 24
Up-regulated 0 2 91 123 1679 2997
Down-regulated 0 1 26 65 2034 2492
Total 0 3 117 188 3713 5489
Number of significantly differentially regulated genes (p < 0.05) at each of the
sampling time points after a period of co-incubation of H. pylori in AGS cells
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shown in Table 2).
Because GO analysis simply associates differentially
expressed genes with the ontologies, there is no attempt
at ranking the true biological significance of individual
genes or ontologies. Therefore, we included only genes
with a log2FC > 1.5 in the GO analysis, excluding lesser
significantly expressed genes that were likely to result in
erroneous GO ranking. Only terms categorized under
Biological Processes are included (Table 2), as these
were the focus of the study. No GO terms were
enriched at 0.5 or 1 h time points. Among the up-regu-
lated genes at 3-6 h, the most frequently associated GOs
were anti-apoptosis, and several inflammatory and anti-
microbial processes such as regulation of retroviral gen-
ome replication, T-helper 1 cell differentiation, chemo-
taxis, neutrophil activation and immune activation. At
12-24 h, the up-regulated genes enriched ontologies like
cell cycle arrest, apoptosis, stress response, amino acid
transport, angiogenesis and keratinization, while certain
biosynthetic processes are among the down-regulated
terms.
Hierarchical clustering of the 245 genes with a log2FC
> 1.5 formed 5 distinct clusters (A-E), at a distance
threshold of 0.54, (Figure 3). Each cluster was examined
for GO and cellular signal pathway associations (Table
3). GO analysis provided significant terms for all clusters
(p < 0.05). Table 3 shows the top 10 significantly
impacted cellular signaling pathways within each cluster,
ranked according to IF. Cluster A contained 9 genes,
and demonstrated steady levels at 6-12 h before showing
a decline. Three genes were involved in anti-apoptotic
processes and two genes were involved in MAPK signal-
ing. Only 3 genes were assigned to cluster B, where
Figure 2 Venn diagrams of significantly regulated genes. Venn
diagrams of differentially expressed genes of H. pylori-infected AGS
cells compared to control cells (p < 0.05). The intersecting circles
indicate overlapping genes at the indicated time points. AGS =
non-infected control AGS cells.
Figure 3 Hiarchical clustering of the most significantly
differentially regulated genes. Hiarchical clustering of significantly
differentially regulated genes (log2FC > 1.5, p < 0.05). Arrow points
at IL-8.
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Page 4 of 15Table 2 Time course: KEGG cellular pathways and gene ontology
Time KEGG cellular pathway name IF GO up-regulated genes GO down-regulated genes
0.5 No significant genes No significant genes No significant genes
1 Epithelial cell signaling in Helicobacter pylori
infection
16.6 No significant GO No significant genes
Cytokine-cytokine receptor interaction 8.1
Bladder cancer 7.5
Toll-like receptor signaling pathway 6.6
Base excision repair 6.0
Primary immunodeficiency 5.9
Pathways in cancer 5.4
3 Epithelial cell signaling in Helicobacter pylori
infection
17.8 anti-apoptosis No significant GO
Pathways in cancer 16.9 regulation of retroviral genome
Small cell lung cancer 14.2 replication
MAPK signaling pathway 14.2 T-helper 1 cell differentiation
Apoptosis 12.5 negative regulation of LPS-mediated signaling
pathway
Adipocytokine signaling pathway 12.3 negative regulation of smooth muscle cell
migration
Prostate cancer 11.4 regulation of MAP kinase activity chemotaxis
Toll-like receptor signaling pathway 11.1 protein amino acid dephosphorylation
T cell receptor signaling pathway 10.5 neutrophil activation
B cell receptor signaling pathway 9.9 entrainment of circadian clock
6 Phosphatidylinositol signaling system 32.2 anti-apoptosis No significant GO
Epithelial cell signaling in Helicobacter pylori
infection
15.5 regulation of retroviral genome
Small cell lung cancer 14.2 replication
Pathways in cancer 12.4 T-helper 1 cell differentiation
Apoptosis 11.6 neutrophil activation
Adipocytokine signaling pathway 10.1 negative regulation of I-kappaB
Toll-like receptor signaling pathway 8.9 kinase/NF-kB cascade
MAPK signaling pathway 8.7 induction of positive chemotaxis
Bladder cancer 8.5 myeloid dendritic cell differentiation
B cell receptor signaling pathway 8.3
12 Leukocyte transendothelial migration 309.7 cell cycle arrest response to unfolded protein
Cell adhesion molecules (CAMs) 75.4 amino acid transport S-adenosylmethionine biosynthetic
process
DNA replication 25.0 positive regulation of transcription
Cell cycle 20.0 response to stress
Pathways in cancer 19.4 regulation of MAP kinase activity
p53 signaling pathway 17.0
Antigen processing and presentation 15.7
MAPK signaling pathway 13.2
Small cell lung cancer 12.2
Circadian rhythm 11.9
24 Leukocyte transendothelial migration 80.3 keratinocyte differentiation cholesterol biosynthetic process
Cell cycle 24.4 amino acid transport response to unfolded protein
p53 signaling pathway 20.9 keratinization isoprenoid biosynthetic process
Circadian rhythm 18.6 angiogenesis creatine biosynthetic process
DNA replication 18.0 apoptosis response to oxidative stress
Adherens junction 16.1 response to stress
Pathways in cancer 14.9 cell cycle arrest
Nucleotide excision repair 14.3 pyrimidine nucleotide metabolic
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ing the first 3 h, followed by a decline. Of the 3 genes
in the cluster, IL-8 and CXCL2 seemed to dictate many
of the acute inflammatory processes like chemotaxis,
immune response and neutrophil activation.
Cluster C comprised the largest cluster, and contained
150 genes that did not show any change until after 6-12
h. The GO terms apoptosis, cell cycle arrest and stress
response genes were markedly enriched, and many of
these genes such as JUN, GADD45A, DDIT3, MKNK2,
DUSP1, RPS6KA5, FLNC,a n dRASGRP were also
involved in MAPK signaling. Furthermore, CSF2RA,
IL24, IL20R and the oncogene PIM1 were involved in
Jak-STAT signaling and cytokine-cytokine signaling.
Cluster D showed a moderate increase peaking at 12
h, followed by a decrease towards 24 h. 13 genes were
assigned to this cluster, including EDN1, one of the iso-
forms of the potent vasoconstrictor endothelin, which
enriched virtually all of the listed GOs. NFKB2,o n eo f
two NF-B subunits, HBEGF and ETS1 were also
included in this cluster.
Cluster E demonstrated 71 genes that showed down-
regulation after 6-12 h and included FGFR3 and several
heat shock protein genes that were involved in the
MAPK signaling pathway and apoptosis inhibition. Also,
several GO biosynthetic processes were enriched.
To confirm the microarray results, we chose to verify
IL-8, as this was the single most differentially regulated
gene in the study. mRNA and protein were sampled at
t h es a m et i m ep o i n t sa n ds t u d i e db yr t - P C Ra n dE L I S A
(Figures 4 and 5). There was an increase in IL-8 mRNA
noticeable after 1 h and peaking at around 3 h. The IL-8
mRNA response then dropped towards 6 and 12 h. At
24 h there was a second increase, however with note-
worthy variance between the two experiments. At 0.5
and 1 h of co-culture, IL-8 protein levels were low and
did not show any change. Between 3 and 6 h of co-cul-
ture, there was a significant IL-8 increase which showed
no further increase after 6 h.
Lastly, we wanted to ascertain that the chosen MOI
was stable with regard to AGS gene expression. We
used IL-8 response as an indicator of gene expression,
and AGS cells were co-incubated with H. pylori for 3 h
at various MOI in two separate experiments (Figure 6).
There was a modest IL-8 response at MOI 15:1 and
150:1, with a remarkable increase at MOI of 300:1.
There were then negligible changes in IL-8 expression
above 300:1, which suggested that the original inoculum
of 300:1 was adequate to elicit a biological response
without overloading the cell culture system.
Discussion
In this study we demonstrate a significant, immediate
response from AGS cells to the exposure to a H. pylori
strain obtained from a clinical setting. More than 6000
human genes showed statistically significant differential
regulation during the first 24 h of co-incubation.
H. pylori infection has been associated with both sti-
mulation and inhibition of apoptosis. Some cell culture
experiments demonstrate up-regulation of genes asso-
ciated with apoptosis [7,8], whereas some in vivo studies
demonstrate proliferation and apoptosis inhibition
[9,10]. VacA toxin has been shown to cause apoptosis in
several studies [30-33], whereas the role of CagA is con-
flicting. CagA has been associated with both stimulation
and inhibition of apoptosis [11,12,34]. Biliary cells
exposed to cagA
+ H. pylori a tav e r yl o wi n o c u l u m
(MOI 1:1) demonstrated increased cell growth, whereas
at MOI of 200:1, apoptosis was stimulated [35]. CagA
may even directly antagonize the pro-apoptotic effect of
VacA, as seen in AGS cells [31]. Apoptosis occurs after
a number of cellular events, leading to activation of cas-
pase-3, which is thought to constitute the basic effector
of apoptosis. In the present study, both inhibitory and
stimulatory genes showed significant differential expres-
sion, demonstrating the complexity of the influence of
H. pylori on apoptosis: caspase inhibitors HSPA5 and
DHCR24 showed similar late down-regulation as heat
shock genes HSPA1B, HSPB1, which are also associated
with apoptosis stimulation (cluster E, Table 3). On the
other hand, TNFAIP3, BIRC2, BIRC3 and SERPINB2,
also associated with apoptosis inhibition, demonstrated
early and persistent up-regulation grouped together in
cluster A. However, positive regulators of apoptosis
PTPRH, TNFRSF12A, IL24, GADD45A, TRIB3, DDIT4,
PHLDA4, PP1R15A and SQSTM1 were all up-regulated
in similar pattern after 6-12 h (cluster C). MCL1,a n
anti-apoptotic gene expressed in response to CagA
injection [11], demonstrated increasing up-regulation
over the course of the study. There were no significant
changes in BCL-2 and very little increase in BAX expres-
sion in our study, two important genes that determine
the sensitivity of cells to other apoptotic stimuli [36-39].
Noteworthy, there was marked up-regulation of
Table 2 Time course: KEGG cellular pathways and gene ontology (Continued)
Ubiquitin mediated proteolysis 14.2 process
Phosphatidylinositol signaling system 13.7 induction of positive chemotaxis
Significantly impacted KEGG cellular pathways and enriched Gene Ontology terms (biological processes only) (p < 0.05) at different time points following co-
culture of H. pylori and AGS cells. Top 10 pathways/ontologies included where number exceeds 10. IF = impact factor
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Temporal profile over 24 h Cellular Pathway Impact
Factor
GO
number
GO name
MAPK signaling pathway 7.3 GO:0006916 anti-apoptosis
Apoptosis 7.1 GO:0045063 T-helper 1 cell differentiation
GO:0031665 negative regulation of LPS-mediated signaling
pathway
GO:0014912 negative regulation of smooth muscle cell migration
GO:0043405 regulation of MAP kinase activity
Epithelial cell signaling in
H. pylori infection
12.4 GO:0006935 chemotaxis
Cytokine-cytokine receptor
interaction
10.2 GO:0006954 inflammatory response
Bladder cancer 6.8 GO:0006955 immune response
Toll-like receptor signaling
pathway
5.9 GO:0045091 regulation of retroviral genome replication
Pathways in cancer 4.8 GO:0042119 neutrophil activation
GO:0050930 induction of positive chemotaxis
GO:0030593 neutrophil chemotaxis
GO:0030155 regulation of cell adhesion
GO:0019722 calcium-mediated signaling
Circadian rhythm 20.0 GO:0006915 apoptosis
MAPK signaling pathway 10.7 GO:0006950 response to stress
mTOR signaling pathway 7.5 GO:0007050 cell cycle arrest
Tight junction 7.0 GO:0030216 keratinocyte differentiation
Jak-STAT signaling
pathway
6.7 GO:0006865 amino acid transport
Cytokine-cytokine receptor
interaction
6.5 GO:0031424 keratinization
Regulation of autophagy 6.4 GO:0008652 amino acid biosynthetic process
p53 signaling pathway 5.6 GO:0006220 pyrimidine nucleotide metabolic process
Regulation of actin
cytoskeleton
5.2
TGF-beta signaling
pathway
5.2
Natural killer cell mediated
cytotoxicity
4.7
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Page 7 of 15TP53BP2, an important tumor suppressor gene (TSG) in
human cancer, primarily stimulating p53 promotion of
apoptosis genes. On the other hand, TP53BP2 is coding
ASPP2 protein, which has also been shown to stimulate
apoptosis independently of p53 [40-42]. However, Buti
et al. recently demonstrated that CagA injected into gas-
tric epithelial cells targeted ASPP2 protein to inhibit
p53-mediated apoptosis [12]. The increased TP53BP2
expression seen in our study, might therefore potentiate
this effect by increasing the CagA-ASPP2 interaction to
cause increased inhibition of p53-mediated apoptosis. In
fact, the current study show e dt h a tp 5 3t a r g e tg e n e s
involved in apoptosis [43] such as FAS, DR4,
TNFRSF10B ( a l s or e f e r r e dt oa sDR5/KILLER), DCR1,
DCR2, P53AIP1, CASP6, APAF1 and BNIP3L did not
show any significant increase, and BNIP3L, CASP6 and
APAF1, BID and BAX showed only little increase. p53
target genes regulating non-apoptotic cellular processes
including MDM2, GADD45A, CDKN1A (also known as
P21 WAF1/CIP1), EGFR, CCND1, CCNG2 and TGFA
demonstrated moderate to marked up-regulation. This
differential gene expression identified among the p53
target genes in this study, may indicate selective inhibi-
tion of p53-mediated apoptosis due to increased CagA-
ASPP2 interaction, consistent with Buti’s findings.
Nevertheless, this study was not designed to assess
whether the overall sum of inhibitory and stimulatory
signals facilitated apoptosis or proliferation of epithelial
cells. The current results illustrate the complexity of
apoptosis regulation in epithelial cells in response to H.
pylori exposure, and the cluster analysis suggests that
there is some biological coordination of gene expression
Table 3 Cluster profiling: KEGG cellular pathways and Gene Ontology (Continued)
Melanogenesis 8.3 GO:0030146 diuresis
GnRH signaling pathway 7.6 GO:0030147 natriuresis
ErbB signaling pathway 6.7 GO:0048661 positive regulation of smooth muscle cell
proliferation
Pathways in cancer 6.4 GO:0002268 follicular dendritic cell differentiation
Epithelial cell signaling in
H. pylori infection
5.7 GO:0031583 activation of phospholipase D activity by G-protein
coupled receptor protein signaling
GO:0014826 vein smooth muscle contraction
GO:0002467 germinal center formation
GO:0030578 PML body organization
GO:0030195 negative regulation of blood coagulation
GO:0043507 positive regulation of JUN kinase activity
Antigen processing and
presentation
13.7 GO:0006695 cholesterol biosynthetic process
MAPK signaling pathway 9.7 GO:0006986 response to unfolded protein
Bladder cancer 6.2 GO:0006916 anti-apoptosis
Pathways in cancer 6.1 GO:0006139 nucleobase, -side, -tide and nucleic acid metabolic
process
Regulation of actin
cytoskeleton
6.1 GO:0008299 isoprenoid biosynthetic process
GO:0006601 creatine biosynthetic process
GO:0009416 response to light stimulus
GO:0043154 negative regulation of caspase activity
GO:0007566 embryo implantation
Temporal profiles of 5 main clusters identified by hiarchical clustering of the 245 most differentially expressed genes (p < 0.05) and associated gene ontologies
(biological processes only) and KEGG cellular signaling pathways in each cluster in H. pylori exposed AGS cells. Data points are at 0.5, 1, 3, 6, 12 and 24 h of co-
incubation. Error bars represent ± standard deviation of expression within the cluster. Top 10 ontologies listed where number is exceeding 10
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plex carcinogenic mechanism of H. pylori in gastric ade-
nocarcinoma. There is strong association between H.
pylori infecton, in particular the cagA
+ genotype [44],
and gastric adenocarcinoma [45,46], and also other can-
cers have been suggested to harbour a role for H. pylori
[47,48]. Furthermore, the present study shows that sev-
eral cancer-related KEGG pathways are impacted in
AGS cells during 24 h of cagA
+ H. pylori infection, in
particular pathways in cancer, bladder cancer, prostate
cancer, small cell lung cancer and the MAPK pathway.
Several individual oncogenes and cancer related genes
were also increased during, and at the end of the study,
including A N G P T 2 ,C E B P B ,E C G F 1 ,M M P 7 ,M M P 1 0 ,
JUN, FOSB, EGFR, CTNNB1, ANXA1, CD55, CLDN1,
KLK6, KRT7, LCN2, MYC, PIM1, PIM2, PIM3 and
ATF3.
IL-8 appears paramount in the acute inflammatory
response to H. pylori infection, as this gene is involved
in all significant response pathways in the initial cellular
response to infection. Several authors have demon-
strated increase in IL-8 in response to H. pylori in both
in vivo [49] and in vitro [50,51] studies. IL-8 is a key
chemokine in accumulating neutrophils. Gastric mucosal
IL-8 levels have shown a positive correlation with the
degree of stomach corpus inflammation [52], and IL-8 is
also highly increased in gastric cancer [53,54]. Our find-
ings are supported by other authors who have demon-
strated that IL-8 mRNA in vitro peaks between 2 and 4
h before decreasing over the next hours under similar
conditions [55,56]. Protein studies have shown steady
state IL-8 levels after 3 h [50,57,58], which is also in
harmony with our ELISA results, where marked IL-8
levels were detectable at 3 h and continuing to increase
at 6 h before reaching a steady level. H. pylori-induced
IL-8 secretion may be explained by both stimulation of
Figure 4 Time-course of IL-8 mRNA expression in AGS cells co-
cultured with H. pylori. Quantitative PCR analysis of IL-8 expression
in H. pylori-infected AGS cells at six different sampling points over
24 h. Data points are the values of three cell culture replicates from
two independent experiments, A and B. Lines represent the
calculated mean within each of the experiments.
Figure 5 Time-course of IL-8 protein expression in AGS cells
co-cultured with H. pylori. ELISA analysis of IL-8 protein expression
in H. pylori-infected AGS cells at six different sampling points over
24 h. Data points are the values of three cell culture replicates from
two independent experiments, A and B. Lines represent the
calculated mean within each of the experiments.
Figure 6 Dose-response of IL-8 mRNA expression in AGS cells
co-cultured with H. pylori. Quantitative PCR analysis of IL-8
expression in H. pylori-infected AGS cells, co-incubated for 3 h. Data
points are the values of three cell culture replicates from two
independent experiments, A and B. Lines represent the calculated
mean within each of the experiments.
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Page 9 of 15the MAPK signaling system [59,60], and NF-B activa-
tion through several pathways [61,62]. In the present
study, MAPK signaling was ranked relatively high from
3 h onwards, based on IF calculations, and the cluster
analysis showed that increasingly more genes in the
MAPK pathway were affected after 6 h of H. pylori
exposure. Regulators of NF-B; TNFAIP3, RELB and
BIRC3, which could also have explained the IL-8 expres-
sion, show increasing expression after 3 h (Additional
file 1: Table S1), identical to the findings of Guillemin et
al. [29]. Therefore, it is interesting that the great
increase in IL-8 mRNA, which peaked as early as 3 h as
shown in both the microarray and rt-PCR data, occurs
before the onset of both MAPK and NF-B signaling.
The rt-PCR data, but not the microarray analysis, also
demonstrated a second increase in IL-8 mRNA at 24 h,
although with noteworthy variance between experi-
ments. While it is possible that this second surge may
be explained by MAPK and/or NF-B activation, it is
unlikely that MAPK or NF-B signaling explain the
initial, powerful IL-8 mRNA peak seen at 3 h. The pre-
sent study is the first to demonstrate that among more
than 38 000 human genes, IL-8 was the single most up-
regulated gene by gastric epithelial cells in response to
H. pylori exposure in vitro, and it appears feasible that
mechanisms other than MAPK or NF-B activation may
be responsible for this up-regulation.
Although histopathological studies indicate that MOI
around 10:1 appear in H. pylori-colonized gastric
mucosa, laboratory conditions can never replicate the
complex physiology of the human stomach. Much
higher MOI have normally been used to study in vitro
gastric epithelial cell response to H. pylori colonization,
and MOI of 300:1 was our incoulum of choice, as we
wanted a sufficient inoculum to induce a biological
response from AGS cells, both at the mRNA and pro-
tein levels, as indicated by other experiments [35,63-71].
However, it is worth noting that in a recent report by
Ritter et al., a marked IL-8 response from AGS cells
exposed to cagA
+ H. pylori was seen at MOI ranging
from 10:1 to 100:1 [61]. The IL-8 response was higher
at MOI 100:1 compared to 10:1 in all the bacterial
strains tested. The response to MOI 300:1 was not
assessed. Neither cagA nor vacA status seemed to affect
the IL-8 response at the higher inoculum. Ritter’s study
also showed that different cellular pathways were acti-
vated in response to high or low MOI. In some other
studies, where non-gastric cells were exposed to cagA
+
H. pylori, low MOI was associated with apoptosis inhibi-
tion and cell growth, whereas high MOI stimulated
apoptosis and inhibited survival [35,72,73]. Hence, the
choice of MOI may be crucial for the study outcome.
Nevertheless, based on our immunofluorescence studies,
where we found sufficient bacterial adhesion to AGS
cells, typical morphological changes, and most impor-
tantly, a marked IL-8 mRNA and protein response to
MOI 300:1, we concluded that under our experimental
conditions, 300:1 was adequate to elicit a biological
response without overloading the system.
You et al. performed a similar microarray study pub-
lished in 2010 [74], where AGS cells were exposed to H.
pylori for 6 h. A relatively stable number of 300-400
genes were reported to be differentially expressed at
each of the sample points, whereas our data showed a
progressive increase in the number of genes from 0.5 to
24 h. In addition, key biological processes like chemo-
taxis, TLR signaling and epithelial cell signaling were
reported as down-regulated. This is in contrast to our
results, and also the findings of most other similar
microarray studies [19-23,25,26,28,29,68,75], where these
particular processes are regularly increased. However,
many of these studies do indeed show somewhat con-
flicting results, possibly explained by differences in incu-
bation conditions, bacterial strains and obsolete or
proprietary cDNA arrays and technology.
We have previously suggested a potential role for
OMPLA in inflammation [14,16]. OMPLA
+ variants
were found to yield increased hemolysis, adherence and
release of urease and VacA compared to the OMPLA
-
variant. One of the aims of the present study was there-
fore to investigate the role of OMPLA on the gastric
epithelial cell inflammatory response. We compared the
gene expression profile of H. pylori OMPLA
+ exposed
cells against OMPLA
- exposed cells at the 6 different
time points. No significant difference was detected at
any of the time points.
No other studies have directly investigated the role of
OMPLA on the gastric epithelial cell inflammatory
response, as the pldA/OMPLA status is unknown in
most strains. Among the few full genome sequenced H.
pylori strains, G27 carries a C7 repeat in the pldA gene
[76] and B38 carries a C9 repeat, both giving rise to a
truncated and inactive OMPLA [77]. Several experi-
ments have demonstrated the ability of G27 to induce a
significant IL-8 response [29,78], supporting our current
observation that OMPLA
- H. pylori is indeed capable of
inducing significant inflammation. One surprising result
has been reported in a study of pH-regulated gene
expression in the G27-strain [79], where Merrell et al.
reported that cagA was consistently suppressed by low
pH in H. pylori G27. Previous studies of other H. pylori
strains, however, had suggested that cagA expression
was induced at low pH.
Although the pldA phase variation did not appear to
affect the inflammatory response in this study, phase
variation of the pldA gene probably serves a purpose in
other aspects of H. pylori. OMPLA activity is associated
with increased survival at low pH [13,80]. The
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possibility might be that OMPLA has adapted an as yet
unknown function needed for this specific environment,
in addition to phospholipase activity. Dorrell et al. have
showed that a pldA knockout mutant was unable to
colonize mice [81]. Salaün et al. have assessed changes
in a spectrum of H. pylori phase-variable genes in a
mouse model of gastric colonization [82]. pldA was
among the most rapidly changing genes, with changes
occurring within the first 3 days of colonization. The
change in pldA showed a phenotypic selection from an
initial inoculum which consisted of a mixture of ON
and OFF phenotypes, to an exclusively ON population.
Wernegreen et al. have postulated that evolutionary
selection will interrupt a slippery tract, such as the C-
tract in the pldA gene, thus removing the possibility of
phase variation [83]. When selection does not happen,
the sequence feature must be to some benefit for the
bacterium. It seems clear that the normal gastric envir-
onment is optimal for the OMPLA
+ phenotype, but for
what niche the OMPLA
- phenotype is adaptive is cur-
rently unknown. One could speculate that the properties
of the OMPLA
- variant could be useful when transfer-
ring from one human stomach to another.
Conclusions
In summary, we have confirmed important biological
processes and pathways affected by H. pylori infection of
gastric epithelial cells described by many other authors.
IL-8 was the single most differentially regulated gene
among more than 38 000 genes tested, and seems fun-
damental in the epithelial cell reaction to H. pylori
demonstrated by its involvement in the majority of the
response processes that we have identified. Several intra-
cellular signaling pathways are significantly impacted,
such as the epithelial cell signaling in H. pylori infection
pathway including the MAPK and NF-Bp a t h w a y s ,
however none of these pathways seem to explain the
very rapid up-regulation of IL-8 seen at 3 h. Further-
m o r e ,w eh a v eo b s e r v e dd i f f e r e n t i a le x p r e s s i o no fb o t h
stimulatory and inhibitory apoptosis genes, suggesting
dysregulation of apoptosis following H. pylori infection.
Apoptotic p53 target genes showed little changes in reg-
ulation, whereas many non-apoptotic p53 target genes
demonstrated a marked increase in expression. This
phenomenon may be explained by selective inhibition of
p53 caused by the ASPP2-CagA interaction.
Lastly, although gastric carcinogenesis is a very
delayed consequence of H. pylori infection, we have
seen up-regulation of cancer-related signaling, as well as
aberrant regulation of oncogenes and TSGs as early as
the first 24 h of infection.
The work presented in this study does not support the
previous suggestion that OMPLA enzyme activity
enhances inflammatory response induced by H. pylori in
epithelial cells. However, the phase shift seen in the
pldA gene probably plays a role in other aspects in the
life of the bacterium.
Methods
Human gastric epithelial cells were infected by the
OMPLA
+ and OMPLA
- H. pylori,a n dm R N Aa n dp r o -
tein were sampled at 6 different time points within the
first 24 h. The co-cultures were studied by immuno-
fluorescent microscopy at 3 and 6 h to study bacterial
adhesion and cell morphological changes. First, human
whole genome cDNA microarray analysis was conducted
to study gene expression changes in the H. pylori-
exposed cells. Second, the epithelial cell response to the
OMPLA
+ variant was compared against the OMPLA
-
variant. Third, IL-8 levels were analyzed by real-time
PCR and ELISA to verify the microarray results. Last, a
dose-response experiment was performed to ensure ade-
quate bacterial inocula.
Bacterial strain and variants
The bacterial strain, H. pylori 17B/RH, a representative
isolate displaying pldA phase variation, was isolated
from a non-ulcer dyspeptic patient referred to outpati-
ent endoscopy and maintained at -70°C [13]. The two
pldA phase variants gave rise to a functional phospholi-
pase A (OMPLA
+) and a truncated, non-functional
phospholipase A (OMPLA
-) respectively. The isogenicity
of the variants was previously confirmed by amplified
fragment length polymorphism [13]. The variants had
the s1a/m2 vacA genotype and were cagA positive dis-
playing an ABC EPIYA genotype [16,80]. The presense
of the caga, cagb, cagE, cagL, cagM, cagX and cagY
genes indicated that the variants harboured an intact
cag pathogenicity island (cagPAI) and were capable of
CagA translocation (unpublished data). Both variants
displayed a truncated LPS.
The bacteria were cultured on blood agar plates under
microaerobic conditions at 37°C for 48 h. After cultiva-
tion, the bacteria were harvested and suspended in
p h o s p h a t eb u f f e r e ds a l i n e( PBS). Bacterial concentra-
tions were estimated by measuring OD600.A l i q u o t so f
the OMPLA
+ and OMPLA
- bacterial suspensions were
transferred to separate cell culture flasks at appropriate
concentrations. Dilutions of the suspensions were also
plated onto blood agar plates. After 5 days of microaero-
bic incubation, the colonies were counted and inspected
for any OMPLA phase shifts.
AGS cell line and inoculation of cell cultures
The gastric epithelial cell line AGS (American Type
Culture Collection no: CRL 1739) was grown on RPMI
supplemented with 2 mM L-glutamine and 10% foetal
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tion of 5% CO2 and 20% O2. When cells grew to a con-
fluent monolayer of approximately 5,1 × 10
6 cells/flask
(60%) the medium was changed to RPMI supplemented
with 2 mM L-glutamine only. After an equilibration per-
iod of about 30 min, bacteria in PBS were added. To
study AGS cell gene expression during the first 24 h,
the cells were co-cultured with the H. pylori at a multi-
plicity of infection (MOI) of 300:1. The two phase var-
iants (OMPLA
+ and OMPLA
-) were assigned to
separate co-cultures, to allow the investigation of the
w h o l eg e n o m er e s p o n s et oH. pylori infection per se,
and also to study possible differences in the response to
the OMPLA
+ and OMPLA
- variants. Co-cultured cells
were incubated for 30 min, 1, 3, 6, 12 and 24 h, before
RNA was stabilized by RNAlater (Applied Biosystems,
United States), and the cells were harvested.
To ensure that the obtained gene response was ade-
quate, a dose-response experiment was performed, add-
ing bacteria to AGS cells at a MOI of 15:1, 150:1, 300:1,
600:1, 900:1 and 1200:1. Cells were co-incubated for 3
h, before being immersed in RNAlater followed by har-
vesting of the cells. Non-infected AGS cells served as a
negative control. Both the time-course and the dose-
response experiments were carried out in three cell cul-
ture replicates and independently performed twice on
separate days.
Microscopy and immunofluorescent staining
Briefly, the bacteria were added to AGS cells grown on
glass coverslips at a MOI of 300:1. The cells were co-
incubated for 3 and 6 h and then fixed by 4% formalin.
Following blocking with 5% bovine serum albumin in
PBS for 30 min, the bacteria were stained with rabbit
anti-Helicobacter antibody (FITC, 1:200, ab30954,
ABCAM PLC, USA) for 1 h at room temperature. Sub-
sequently, the AGS cells were morphologically examined
using a fluorescent microscope (Olympus IX81, Olym-
pus, Japan) under a 40x objective.
RNA isolation, quality control and cDNA synthesis
Total RNA was isolated using RNeasy Mini (Qiagen
GmBH, Germany) according to the manufacturer’sp r o -
tocol. RNA concentration and quality were determined
using a NanoDrop ND-1000 spectrophotometer (Nano-
Drop Technologies, USA) and Agilent 2100 Bioanalyzer
(Agilent Technologies, USA). For real-time PCR, cDNA
was prepared using a First-Strand cDNA Synthesis Kit
(GE Healthcare, USA), according to standard protocol.
The Illumina TotalPrep RNA amplification Kit
(Ambion Inc., USA) was used to amplify RNA for hybri-
dization on Illumina BeadChips. To synthesize first
strand cDNA by reverse transcription, we used total
RNA from each sample collected above. Following the
second strand cDNA synthesis and cDNA purification
steps, the in vitro transcription to synthesize cRNA was
prepared overnight for 12 h.
Real-time PCR analysis
Each sample was tested in triplicate by real-time quanti-
tative PCR (rt-PCR) on the 7900HT Fast Real-Time
PCR system (Applied Biosystems). Expression of IL-8
was analyzed using custom IL-8 primer and probe (part
no: 4331348, assay ID: Hs00174103_m1, Applied Biosys-
tems). Mean cycle time (Ct) was calculated, and the
comparative Ct-method [84] was utilized to control for
background gene expression using reference gene
GADPH (part no: 4333764F, Applied Biosystems).
ELISA
IL-8 protein was measured in the cell culture superna-
tant by the Quantikine Human CXCL8/IL-8 enzyme
linked immunosorbent assay (ELISA) kit, according to
manufacturer’s instructions (R&D Systems, USA). The
test samples were not diluted. Serial dilutions of recom-
binant human IL-8 were used for standard curves. The
optical density of the wells was determined using a
microtitre plate reader (Varioskan, Thermo Scientific,
USA) set to a wavelength of 450 nm, with wavelength
correction set to 540 nm
cDNA oligonucleotide microarray analysis
The gene expression profiles were measured using Illu-
mina Human HT-12 v3 Expression BeadChip (Illumina,
USA), which enables genome-wide expression analysis
(48 800 transcripts, corresponding to approximately 37
800 genes) of 12 samples in parallel on a single microar-
ray. 35967 of the probes were designed using the RefSeq
(build 36.2, release 22) library and 12.837 probes were
derived from the UniGene (build 199) database [85,86].
Bioinformatics and statistics
R/BioConductor [87,88], with the package Beadarray
[82], were used for preprocessing of the microarray
text data from BeadStudio. Spatial artifacts were
removed using BASH [89] before the expression data
were log2-transformed and quantile normalized. Mod-
erated t-tests [90] were then performed for each probe
on the array to test whether the differential expression
between the starting point and the later time points
was significant. To account for multiple testing,
adjusted p-values were calculated by controlling the
false discovery rate (FDR), using the Benjamini-Hoch-
berg procedure [91]. The differential expression was
declared significant if the adjusted p-value (FDR q-
value) < 0.05. The analysis was performed using the R
statistical package [87] and the limma software package
from Bioconductor [88].
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entially expressed genes, lesser expressed genes were fil-
t e r e do u t .Ac u t o f fl e v e la tl o g 2 fold change (log2FC) >
1.5 was applied to the total genelist of 6237 significant
genes (Additional file 1: Table S1), producing a list of
the 245 most differentially expressed genes (Additional
file 2: Table S2). For the selected genes, all 6 corre-
sponding fold change values, including non-significant
values, were assigned to the genelist for hierarchical
clustering. Assuming that similarly expressed genes may
share some of the same biological functions, the goal of
hierarchical clustering is to group together genes with
similar expression. In a time course study, it is most
biologically relevant to cluster together genes that have
a similar expression pattern, rather than expression
magnitude. Consequently, the Pearson correlation coeffi-
cient was the appropriate distance measure in the clus-
tering of our results.
Data were imported into Multi Experiment Viewer v
4.6.0 (MeV) software [92] for hierarchical clustering,
and both non-clustered data and the clustered subsets
were entered into Onto-Express and Pathway Express
[93,94], part of the Onto-Tools software suite, for GO
and KEGG signal pathway analysis. Pathway Express cal-
culates an Impact Factor (IF) which is used to rank the
affected pathways, based on the FC and the number of
the involved genes, and the amount of perturbation of
downstream genes [95].
The microarray data are available under the accession
number E-MTAB-846 in the ArrayExpress database
http://www.ebi.ac.uk/arrayexpress.
Additional material
Additional file 1: Table S1. The list of genes that showed significant
differential expression at no less than 1 time point in H. pylori exposed
AGS cells (p < 0.05).
Additional file 2: Table S2. The list of genes that showed significant
log2 fold change > 1.5 in H. pylori exposed AGS cells at no less than 1
time point (p < 0.05).
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